HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients
To access this article, please choose from the options below
The Dialysis Outcomes and Practice Patterns Study is supported by research grants from Amgen Inc and Kirin Brewery Ltd without restrictions on publications. This project was funded in part by Renal Research Institute Inc.
PII: S0272-6386(04)01412-X
doi:10.1053/j.ajkd.2004.09.025
© 2004 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
